Technical Analysis for MNOV - MediciNova, Inc.

Grade Last Price % Change Price Change
C 1.95 2.63% 0.05
MNOV closed up 2.63 percent on Wednesday, November 20, 2024, on 86 percent of normal volume. It was able to find support at its 50 day moving average.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Crossed Above 50 DMA Bullish 2.63%
Wide Bands Range Expansion 2.63%
Fell Below 50 DMA Bearish 8.33%
20 DMA Support Bullish 8.33%
Calm After Storm Range Contraction 8.33%
Doji - Bullish? Reversal 8.33%

   Recent Intraday Alerts

Alert Time
50 DMA Support about 22 hours ago
Rose Above Previous Day's High about 22 hours ago
Down 3% about 22 hours ago
Down 2 % about 22 hours ago
Down 1% about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MediciNova, Inc. Description

MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a ß2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pain Clinical Development Medication Multiple Sclerosis Asthma Respiratory Therapy Central Nervous System Disorders Nervous System Disorders Solid Tumor Cancers Insomnia Molecule Therapeutics Pulmonology Urinary Incontinence Bronchial Asthma Interstitial Cystitis

Is MNOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.55
52 Week Low 1.12
Average Volume 69,907
200-Day Moving Average 1.50
50-Day Moving Average 1.82
20-Day Moving Average 1.75
10-Day Moving Average 1.82
Average True Range 0.18
RSI (14) 56.33
ADX 24.94
+DI 38.95
-DI 17.69
Chandelier Exit (Long, 3 ATRs) 2.01
Chandelier Exit (Short, 3 ATRs) 1.95
Upper Bollinger Bands 2.11
Lower Bollinger Band 1.39
Percent B (%b) 0.78
BandWidth 41.20
MACD Line 0.03
MACD Signal Line 0.01
MACD Histogram 0.0284
Fundamentals Value
Market Cap 95.64 Million
Num Shares 49 Million
EPS -0.19
Price-to-Earnings (P/E) Ratio -10.26
Price-to-Sales 69.40
Price-to-Book 1.07
PEG Ratio -0.94
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.18
Resistance 3 (R3) 2.16 2.06 2.14
Resistance 2 (R2) 2.06 2.01 2.07 2.12
Resistance 1 (R1) 2.01 1.97 2.03 2.03 2.11
Pivot Point 1.91 1.91 1.92 1.92 1.91
Support 1 (S1) 1.86 1.86 1.88 1.88 1.79
Support 2 (S2) 1.76 1.82 1.77 1.78
Support 3 (S3) 1.71 1.76 1.76
Support 4 (S4) 1.73